MENU
+Compare
PIRS
Stock ticker: NASDAQ
AS OF
Dec 13 closing price
Price
$13.60
Change
-$2.53 (-15.69%)
Capitalization
17.96M

PIRS Pieris Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of an anticalin-brand protein technology

Industry Biotechnology
PIRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PIRS with price predictions
Dec 20, 2024

PIRS's Stochastic Oscillator is sitting in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PIRS advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

PIRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 11, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PIRS as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PIRS turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

PIRS moved below its 50-day moving average on December 12, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PIRS crossed bearishly below the 50-day moving average on December 12, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PIRS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.104) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). PIRS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (12.804) is also within normal values, averaging (255.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PIRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PIRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PIRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PIRS is expected to report earnings to fall 320.00% to -10 cents per share on November 08

Pieris Pharmaceuticals PIRS Stock Earnings Reports
Q3'23
Est.
$-0.11
Q2'23
Beat
by $0.21
Q1'23
Est.
$-0.18
Q4'22
Beat
by $0.12
Q3'22
Beat
by $0.03
The last earnings report on August 03 showed earnings per share of 5 cents, beating the estimate of -15 cents. With 51.73K shares outstanding, the current market capitalization sits at 17.96M.
A.I. Advisor
published General Information

General Information

a developer of an anticalin-brand protein technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 246-8998
Employees
50
Web
https://www.pieris.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS7.750.83
+11.99%
Momentus Inc
BRKL11.940.41
+3.56%
Brookline Bancorp
PBA36.410.34
+0.94%
PEMBINA PIPELINE Corp
ALE64.50-0.10
-0.15%
ALLETE
GOEV0.09-0.01
-9.23%
Canoo

PIRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PIRS has been closely correlated with BPTSY. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIRS
1D Price
Change %
PIRS100%
N/A
BPTSY - PIRS
89%
Closely correlated
N/A
FATE - PIRS
51%
Loosely correlated
+1.20%
MDGL - PIRS
39%
Loosely correlated
+5.12%
CYTK - PIRS
38%
Loosely correlated
+4.56%
AXON - PIRS
36%
Loosely correlated
+2.60%
More